↓ Skip to main content

Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, December 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
35 Mendeley
citeulike
1 CiteULike
Title
Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study
Published in
European Journal of Nuclear Medicine and Molecular Imaging, December 2018
DOI 10.1007/s00259-018-4234-6
Pubmed ID
Authors

Ravit Geva, Juanita Lopez, Sarah Danson, Heikki Joensuu, Avivit Peer, Samuel J. Harris, Fabricio Souza, Kaline M. C. Pereira, Ruth Perets

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 11%
Researcher 4 11%
Student > Master 3 9%
Lecturer 2 6%
Student > Doctoral Student 2 6%
Other 5 14%
Unknown 15 43%
Readers by discipline Count As %
Medicine and Dentistry 8 23%
Nursing and Health Professions 3 9%
Business, Management and Accounting 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Physics and Astronomy 1 3%
Other 3 9%
Unknown 17 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2018.
All research outputs
#20,567,353
of 26,017,215 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#2,650
of 3,565 outputs
Outputs of similar age
#327,825
of 449,718 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#25
of 47 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,565 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,718 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.